NMS Group
@nmsgroup.it
NMS is a global, integrated biopharmaceutical company focused on the discovery and development of innovative oncology therapies. With affiliates in Nerviano (Italy), Boston (USA), and Shanghai (China), NMS leverages deep expertise in drug discovery and translational medicine to advance a pipeline of novel candidates from bench to bedside.
NMS Group's Company Logos
NMS Group's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FC0004
Red
252, 0, 4
359, 100, 49
0, 100, 98, 1
#FB6962
Bittersweet
251, 105, 98
3, 95, 68
0, 58, 61, 2
#1032CF
Persian Blue
16, 50, 207
229, 86, 44
92, 76, 0, 19
About NMS Group
NMS Group is a leading brand committed to advancing oncology care. With over 50 years of experience, NMS Group is an international benchmark in personalized therapy for cancer patients. They are headquartered in Nerviano, Italy, and have more than 400 employees across three specialized subsidiaries: Nerviano Medical Sciences, Accelera, and NerPharMa.
Nerviano Medical Sciences is at the forefront of oncology drug discovery and development, with a team of 130 researchers dedicated to finding innovative targeted therapies. Accelera focuses on preclinical research and offers high-level services to biotech and pharmaceutical companies worldwide. NerPharMa specializes in product development, manufacturing, clinical distribution, and regulatory approvals.
NMS Group's unwavering commitment to improving patients' health is driven by their mission to discover, develop, and deliver life-changing molecules. They pride themselves on their values of Perseverance, Respect, Integrity, Dedication, and Empathy. With international certifications and strong collaborations with the scientific community, NMS Group ensures excellence in oncology innovation.
Visit their website to learn more and stay updated on their latest news and events
Brand industry
Science and Education
Company type
Privately Held
Year founded
Suggest founded year
Company size
201-500 employees
